For the first time in over four decades, researchers are returning to examining the therapeutic benefits of mind-altering substances, including MDMA (ecstasy), psilocybin (mushrooms), marijuana and LSD. In the 1970s the study of all psychedelics was criminalized in the US, despite emerging evidence of their medical value. Over the past decade, the Multidisciplinary Association for Psychedelic Research (MAPS) has helped to revive psychedelic research, sponsoring studies across the United States and around the world, including MDMA-assisted therapy for PTSD, and end-of-life anxiety. The results have been very positive, lasting over 72 months of follow-up, with few adverse effects. Psychedelics may promote a deepening and acceleration of the psychotherapeutic process. During therapy, people often are able to access and find peace with disavowed, “exiled” parts of themselves. In this workshop, the principal investigator of the Phase I and II level trials will discuss outcomes and processes. Two of the most prominent neurobiologists of psychedelics, Robin Carhart Harris and Sue Carter will present their findings about fundamental mechanisms, and the Boston MDMA study team will discuss clinical experiences and applications. In appropriate therapeutic contexts, psychedelics may prove to be more effective than most conventional treatments, as well as safer and more cost-effective.
NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after completing the on-line post-test (80% passing score) and completing the evaluation).
Continuing Education Information: Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, please contact cepesi@pesi.com or 800-844-8260 before the event.
Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.
This self-study activity consists of 3.0 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc. is an approved provider by the CADTP, Provider #: 201. This Category H activity meets the qualifications for 3.0 CEU's (continuing education hours).
Provider #120924. This course has been approved as a CCB approved training and has been awarded 3.25 hours by the Connecticut Certification Board.
PESI, Inc. is an Oklahoma Board of Licensed Alcohol and Drug Counselors approved provider #20230032. This self-study activity consists of 3.25 clock hours of continuing education instruction.
PESI, Inc. is recognized by the New York State Education Department's (NYSED) State Board for Mental Health Practitioners as an approved provider of continuing education for Licensed Creative Art Therapists. #CAT-0087. This self-study activity will qualify for 4.0 contact hours. Full attendance is required; no partial credits will be offered for partial attendance.
This self-study activity consists of 3.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc. is an approved provider with the Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling. Provider Number 50-399. This self-study course qualifies for 3.25 continuing education credits.
CE credit is available. This self-study course consists of 4.0 continuing education credit hours for Kentucky Counselors. The Continuing Education Requirements for the Kentucky Board of Licensed Professional Counselors (201 KAR 36:030 Section 2) state continuing education programs from providers sponsored or approved by a state counseling licensure board shall be approved without further review by the board. PESI, Inc. is approved by the South Carolina Board of Examiners for Licensure of Professional Counselors, Marriage and Family Therapists, and Psycho-Educational Specialists. Provider #4540. PESI maintains responsibility for this program and its contents.
The Montana Board of Behavioral Health no longer pre-approves any courses or sponsors. Each licensee is responsible for taking courses which contribute to their competence and directly relate to their scope of practice as defined in board statute (MAR 24-219-32). Licensees must keep CE documentation for three years in case of an audit. This intermediate level self-study activity consists of 3.25 clock hours of instruction.
PESI, Inc. is an approved CEU provider with the State of Nevada Board of Examiners for Marriage and Family Therapists and Clinical Professional Counselors. This self-study activity qualifies for 3.25 contact hours. Approved Provider # NVCEP2006.
This self-study program has been approved for 3.0 continuing education hours by the South Carolina Board of Examiners for Licensure of Professional Counselors, Marriage and Family Therapists, and Psycho-Educational Specialists. Provider #4540.
This self-study activity consists of 3.0 clock hours of continuing education instruction. Texas State Board of Examiners of Professional Counselors no longer approves programs or providers. PESI activities meet the continuing education requirements as listed in Title 22 Texas Administrative Code, Chapter 681, Subchapter J, Section 681.142 Acceptable Continuing Education. Please retain the certificate of completion that you receive and use as proof of completion when required.
This self-study activity consists of 3.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save this course outline, the certificate of completion you receive from this self-study activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc. is an approved provider with the Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling. Provider Number 50-399. This self-study course qualifies for 3.25 continuing education credits.
PESI, Inc. has been approved as a provider of continuing education by the State of Illinois, Department of Professional Regulation. Provider #:168-000156. Full attendance at this self-study activity qualifies for 3.0 credits.
The Montana Board of Behavioral Health no longer pre-approves any courses or sponsors. Each licensee is responsible for taking courses which contribute to their competence and directly relate to their scope of practice as defined in board statute (MAR 24-219-32). Licensees must keep CE documentation for three years in case of an audit. This intermediate level self-study activity consists of 3.25 clock hours of instruction.
PESI, Inc. is an approved CEU provider with the State of Nevada Board of Examiners for Marriage and Family Therapists and Clinical Professional Counselors. This self-study activity qualifies for 3.25 contact hours. Approved Provider # NVCEP2006.
This self-study program has been approved for 3.0 continuing education hours by the South Carolina Board of Examiners for Licensure of Professional Counselors, Marriage and Family Therapists, and Psycho-Educational Specialists. Provider #4540.
This self-study activity consists of 3.0 clock hours of continuing education instruction. Texas State Board of Examiners of Marriage and Family Therapists no longer approves programs or providers. PESI activities meet the continuing education requirements as listed in Title 22 of the Texas Administrative Code, Chapter 801, Subchapter K, Section 801.264 Types of Acceptable Continuing Education. Please retain the certificate of completion that you receive and use as proof of completion when required.
This self-study activity consists of 3.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from this self-study activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc. is a provider approved by the California Board of Registered Nursing, Provider #: 17118 for 3.0 self-study contact hours.
** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.
PESI, Inc. is an approved provider by the Florida Board of Nursing. Provider #: FBN2858. These materials qualify for 3.0 self-study contact hours.
PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 3.3 self-study contact hours. Please email cepesi@pesi.com with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.
PESI, Inc., is an approved provider with the Florida Board of Psychology.Provider Number #50-399.This product qualifies for 3.3 self-study continuing education credits.
This self-study activity consists of 3.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from this self-study activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc is an approved provider with the State of Illinois, Department of Professional Regulation. License #: 268.000102. Full attendance at this self-study course qualifies for 3.0 contact hours.
PESI, Inc. is approved by the Kentucky Board of Examiners of Psychology to offer continuing education for psychologists. PESI maintains responsibility for this program and its content. This self-study activity will qualify for 3.25 contact hours.
PESI, Inc. is approved by the Ohio Psychological Association, Provider #263896894, to sponsor continuing education for psychologists. PESI, Inc. maintains responsibility for this program and its content. PESI is offering this self-study activity for 3.25 Standard hours of continuing education credit.
PESI, Inc. is approved by the Pennsylvania State Board of Psychology to offer continuing education for psychologists. Provider #PSY000211. PESI maintains responsibility for the program(s). This self-study program qualifies for 3.25 continuing education hours.
This intermediate self-study activity consists of 3.25 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc. is an approved provider with the Colorado Chapter of the National Association of Social Workers. Provider #1413. This self-study course has been approved for 3.3 continuing education hours.
COLORADO PARTICIPANTS ONLY: If you did not answer YES to be reported to the Colorado Chapter of the NASW on the evaluation, please contact cepesi@pesi.com and provide the full title of the webcast, speaker name, date of live broadcast, your name and your license number in the email.
PESI, Inc. is an approved provider with the Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling. Provider Number 50-399. This self-study course qualifies for 3.25 continuing education credits.
PESI, Inc. is an approved provider with the State of Illinois, Department of Financial and Professional Regulation, Division of Professional Regulation. License #: 159-000154. Successful completion of this self-study activity qualifies for 3.0 contact hours.
PESI, Inc. is an approved provider with the Kansas Behavioral Sciences Regulatory Board. Provider #14-006. This self-study course has been approved for 3.0 continuing education hours.
PESI, Inc. is an approved provider with the State of Minnesota, Board of Social Work. Provider #: CEP-140. This self-study package has been approved for 3.0 continuing education hours. This certificate has been issued upon successful completion of a post-test.
The Montana Board of Behavioral Health no longer pre-approves any courses or sponsors. Each licensee is responsible for taking courses which contribute to their competence and directly relate to their scope of practice as defined in board statute (MAR 24-219-32). Licensees must keep CE documentation for three years in case of an audit. This intermediate level self-study activity consists of 3.25 clock hours of instruction.
This self-study activity qualifies for 3.25 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.
| Handout - The Use of Mind-Altering Substances (2.5 MB) | 22 Pages | Available after Purchase | |
| Transcript (29.8 KB) | 14 Pages | Available after Purchase |
Michael Mithoefer, MD, clinical assistant professor of psychiatry at the Medical University of South Carolina. In 2009, he completed & published the first FDA approved clinical trial of MDMA assisted psychotherapy for treatment-resistant PTSD, followed by completion of a Phase II trial. He is overseeing a multisite Phase III study of MDMA-assisted psychotherapy in 13 sites around the US (including the Trauma Research Foundation), and another MDMA-assisted psychotherapy multisite study in Europe and Israel.
Speaker Disclosures:
Financial: Dr. Michael Mithoefer has employment relationships with Bassett Healthcare Network, Medical University of South Carolina, and MAPS Public Benefit Corporation. He has an ownership interest in Awakn Life Sciences and serves on the scientific advisory board. Dr. Mithoefer receives a speaking honorarium and recording royalties from PESI, Inc.
Non-financial: Dr. Michael Mithoefer is a fellow of the American Psychiatric Association.
Rick Doblin, PhD, Executive Director, Multidisciplinary Association for Psychedelic Studies (MAPS); chair of the board of directors MAPS Public Benefit Corporation.
Speaker Disclosures:
Financial: Richard Doblin has an employment relationship with Multidisciplinary Association for Psychedelic Studies, Inc. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Richard Doblin has no relevant non-financial relationships.
Phil Wolfson, MD, is president and CEO of the non-profit Ketamine Research Foundation and directs the training of KAP practitioners through The Ketamine Training Center. Phil’s book, The Ketamine Papers, is the seminal work in the burgeoning ketamine arena. His is principal investigator for the MAPS sponsored Phase 2, the FDA-approved 18-person study of MDMA-Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine-Assisted Psychotherapy.
Speaker Disclosures:
Financial: Philip Wolfson is the founder and CEO of The Ketamine Research Foundation. He has an ownership interest in Progressive Therapeutics, Inc. Dr. Wolfson will address off-label uses. He has no relevant financial relationships with ineligible organizations.
Non-financial: Philip Wolfson has no relevant non-financial relationship to disclose.
C. Sue Carter, PhD, is Distinguished University Scientist, Rudy Professor Emerita of Biology at Indiana University Bloomington and from 2014-2019 was Director of the Kinsey Institute. She is Professor Emerita at the University of Illinois at Chicago and formerly held the position of Distinguished University Professor of Biology at the University of Maryland and prior to that was Professor in the Departments of Psychology and Ecology, Ethology and Evolution at the University of Illinois, Urbana-Champaign. Dr. Carter is a past president of the International Behavioral Neuroscience Society and holds fellow status in that Society and in the American Association for the Advancement of Science. She has a career long history of federal research funding include an NIMH Research Scientist Award. Dr. Carter is the scientist who discovered the relationship between social behavior and oxytocin. Her current work examines the developmental consequences of oxytocin and the role of oxytocin pathways in human sociality.
Speaker Disclosures:
Financial: C. Sue Carter is the Distinguished University Research Scientist and Rudy Professor Emerita of Biology at Indiana University. She has no relevant financial relationships with ineligible organizations.
Non-financial: C. Sue Carter has no relevant non-financial relationship to disclose.
Robin Carhart-Harris, PhD, is a psychologist and neuroscientist and Head of the Centre for Psychedelic Research, Division of Brain Sciences, Faculty of Medicine at Imperial College London. He coordinated the first clinical study of psilocybin in the UK and the first clinical study of a classic psychedelic drug in the UK for over 40 years.
After being awarded an MA in Psychoanalysis at Brunel University, London, Carhart-Harris completed his PhD in psychopharmacology at the University of Bristol. In 2009, under the mentorship of Professor David Nutt, he relocated to Imperial College, London to continue his fMRI research with the classic psychedelic psilocybin. In conjunction with David Nutt, he built up a program of psychedelic research that includes fMR and MEG imaging with psilocybin, fMR imaging with MDMA, and plans for an MRC-sponsored clinical trial to assess the efficacy of psilocybin as a treatment for major depression.
Speaker Disclosures:
Financial: Robin Carhart-Harris is the Head of Centre for Psychedelic Research at Imperial College London.
Non-financial: Robin Carhart-Harris is a member of the Association for Psychological Services; Neuropsychoanalysis Association; International Society for Research on Psychedelics; and the British Association for Psychopharmacology. He is an advisory council member for the Massachusetts General Hospital, Psychedelic Research Centre.
Andrew Penn RN, MS, NP, CNS, APRN-BC, UC San Francisco trained psychiatric nurse practitioner. Associate clinical professor in the UCSF School of Nursing, practicing at the San Francisco VA. He has worked as study therapist on a MDMA-assisted therapy protocol for PTSD.
Speaker Disclosures:
Richard Schwartz, PhD began his career as a family therapist and an academic at the University of Illinois at Chicago. There he discovered that family therapy alone did not achieve full symptom relief, and in asking patients why, he learned that they were plagued by what they called "parts." These patients became his teachers as they described how their parts formed networks of inner relationship that resembled the families he had been working with. He also found that as they focused on and, thereby, separated from their parts, they would shift into a state characterized by qualities like curiosity, calm, confidence and compassion. He called that inner essence the Self and was amazed to find it even in severely diagnosed and traumatized patients. From these explorations, the Internal Family Systems (IFS) model was born in the early 1980s.
IFS is now evidence-based and has become a widely-used form of psychotherapy, particularly with trauma. It provides a non-pathologizing, optimistic, and empowering perspective and a practical and effective set of techniques for working with individuals, couples, families, and more recently, corporations and classrooms.
In 2013, Schwartz left the Chicago area and now lives in Brookline, MA where he is on the faculty of the Department of Psychiatry at Harvard Medical School.
Speaker Disclosures:
Financial: Dr. Richard Schwartz is the Founder and President of the IFS Institute. He maintains a private practice and has a employment relationship with Harvard Medical School. He receives royalties as a published author. Dr. Schwartz receives a speaking honorarium, recording, and book royalties from Psychotherapy Networker and PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Richard Schwartz is a fellow of Meadows Behavioral Healthcare and is a member of the American Family Therapy Academy and the American Association for Marital and Family Therapy. He is a contributing editor for Family Therapy Networker. Dr. Schwartz serves on the editorial boards for the Journal of Feminist Family Therapy, the Contemporary Family Therapy, the Journal of Family Psychotherapy, and the Family Therapy Collections.
Anne Wagner, PhD, CPsych, Adjunct Professor, Department of Psychology & Associate Member, Yeates School of Graduate Studies at Ryerson University, Toronto. Trainer in CBCT and CPT. Team member, MDMA trial for Cognitive Behavioral Conjoint Therapy (CBCT) for PTSD. Founder of Remedy (www.remedycentre.ca), a centre for mental health innovation.
Speaker Disclosures:
Financial: Anne Wagner is the founder of Remedy and Remedy Institute and has an employment relationship with Toronto Metropolitan University. She receives compensation as a collaborator and consultant. She receives grants from Philanthropic Donors and Australian National Health and Medical Research Council Innovative Therapies for Mental Health Program. Anne Wagner receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Anne Wagner is a member of the Canadian Psychological Association, the International Society of Traumatic Stress Studies, and Association for Behavioral and Cognitive Therapies. She is an Ad hoc reviewer and editor for several peer review journals, for a complete list contact PESI, Inc.
James W. Hopper, PhD, Independent consultant and Instructor in Psychology, Cambridge Health Alliance & Harvard Medical School. Co-editor, Mindfulness-Oriented Interventions for Trauma: Integrating Contemplative Practices. The MDMA Team, Trauma Research Foundation.
Speaker Disclosures:
Financial: James Hopper maintains a private practice and has employment relationships with Harvard University and Cambridge Health Alliance. He is a sub-investigator and therapist with MAPS/MPBC and The Trauma Research Foundation. James Hopper receives royalties as a published author. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: James Hopper serves on the advisory board for Callisto. He is a member of the International Society for Traumatic Stress Studies and the APA Division 56. James Hopper is an Ad hoc reviewer for several peer review journals, for a complete list contact PESI, Inc.
Elizabeth Call, PsyD, Psychologist in private practice. Therapy team member, MDMA study, the Trauma Research Foundation.
Speaker Disclosures:
Susan Walker, MD, Instructor in Psychiatry, Harvard Medical School. Child and Adolescent Psychiatrist, Cambridge health Alliance. MDMA Therapy Team Member, the Trauma Research Foundation. Co-principal Investigator, Boston Site of MAPS sponsored MDMA for PTSD study.
Speaker Disclosures:
Financial: Susan Walker is a clinical sub-investigator and therapist with MAPS/MPBC and The Trauma Research Foundation. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Susan Walker is a member of the American Psychiatric Association and American Psychiatric Association.
Francis Guerriero, MA, LICSW, Private practice, Cambridge, MA; MDMA Therapy team member, The Trauma Research Foundation.
Speaker Disclosures:
Financial: Francis Guerriero maintains a private practice and has an employment relationship with the Trauma Research Foundation. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Francis Guerriero has a professional relationship as a therapist and sub-investigator under Multidisciplinary Association for Psychedelic Studies (MAPS).
Michael D. Alpert, MD, Staff Psychiatrist, BayCove Mental Health Center, Boston Harvard Medical School; MDMA Therapy team member, the Trauma Research Foundation.
Speaker Disclosures
Financial: Dr. Michael Alpert maintains a private practice and has employment relationships with Quincy Asian Resources Initiative, Baystate Health, MAPS Public Benefit Corporation, Harvard Medical School and Cambridge Health Alliance. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Michael Alpert is a member of the American Psychiatric Association and the Massachusetts Medical Society.
Bessel A. van der Kolk, MD, is a clinician, researcher and teacher in the area of post-traumatic stress. His work integrates developmental, neurobiological, psychodynamic and interpersonal aspects of the impact of trauma and its treatment.
Dr. van der Kolk and his various collaborators have published extensively on the impact of trauma on development, such as dissociative problems, borderline personality and self-mutilation, cognitive development, memory, and the psychobiology of trauma. He has published over 150 peer-reviewed scientific articles on such diverse topics as neuroimaging, self-injury, memory, neurofeedback, Developmental Trauma, yoga, theater, and EMDR.
He is founder of the Trauma Center in Brookline, Massachusetts and President of the Trauma Research Foundation, which promotes clinical, scientific, and educational projects.
His 2014 #1 New York Times best seller, The Body Keeps the Score: Brain, Mind, and Body in the Treatment of Trauma, transforms our understanding of traumatic stress, revealing how it literally rearranges the brain’s wiring – specifically areas dedicated to pleasure, engagement, control, and trust. He shows how these areas can be reactivated through innovative treatments including neurofeedback, somatically based therapies, EMDR, psychodrama, play, yoga, and other therapies.
Dr. van der Kolk is the past president of the International Society for Traumatic Stress Studies, and professor of psychiatry at Boston University Medical School. He regularly teaches at conferences, universities, and hospitals around the world.
Speaker Disclosures:
Access never expires for this product.
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
Please wait ...
